APOA4 Antikörper (AA 21-396)
(2 Referenzen)-
- Target Alle APOA4 Antikörper anzeigen
- APOA4 (Apolipoprotein A-IV (APOA4))
-
Bindungsspezifität
- AA 21-396
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser APOA4 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- APOA4 Antibody
- Aufreinigung
- Ascitic fluid
- Immunogen
- Purified recombinant fragment of APOA4 (aa21-396) expressed in E. Coli.
- Klon
- 1D4C11
- Isotyp
- IgG2a
- Top Product
- Discover our top product APOA4 Primärantikörper
-
anti-Apolipoprotein A-IV (APOA4) (AA 135-281) antibody
APOA4 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A-IV (APOA4) (AA 299-369) antibodyAPOA4 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A-IV (APOA4) (AA 173-396) antibodyAPOA4 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A-IV (APOA4) (AA 21-120) antibodyAPOA4 Reaktivität: Human, Maus, Ratte WB, ELISA, IF (p), IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A-IV (APOA4) (AA 21-391) antibodyAPOA4 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A-IV (APOA4) (AA 1-396) antibodyAPOA4 Reaktivität: Human WB, IHC (p) Wirt: Maus Polyclonal unconjugated
anti-Apolipoprotein A-IV (APOA4) (Internal Region) antibodyVerified APOA4 Reaktivität: Human WB, ELISA Wirt: Ziege Polyclonal unconjugated
anti-Apolipoprotein A-IV (APOA4) (AA 21-382) antibodyAPOA4 Reaktivität: Schwein WB, IHC, IP, ICC Wirt: Maus Monoclonal A8 unconjugated
anti-Apolipoprotein A-IV (APOA4) (AA 49-79), (N-Term) antibodyAPOA4 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB15153 unconjugated
anti-Apolipoprotein A-IV (APOA4) (AA 21-396) antibodyAPOA4 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2D1C9 unconjugated
-
- Applikationshinweise
- ELISA: 1/10000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Ascitic fluid containing 0.03 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
: "Genetic association study of APOA1/C3/A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population." in: Clinica chimica acta; international journal of clinical chemistry, Vol. 388, Issue 1-2, pp. 78-83, (2007) (PubMed).
: "E-cadherin-dependent transcriptional control of apolipoprotein A-IV gene expression in intestinal epithelial cells: a role for the hepatic nuclear factor 4." in: The Journal of biological chemistry, Vol. 281, Issue 6, pp. 3560-8, (2006) (PubMed).
-
: "Genetic association study of APOA1/C3/A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population." in: Clinica chimica acta; international journal of clinical chemistry, Vol. 388, Issue 1-2, pp. 78-83, (2007) (PubMed).
-
- Target
- APOA4 (Apolipoprotein A-IV (APOA4))
- Andere Bezeichnung
- APOA4 (APOA4 Produkte)
- Hintergrund
-
Description: APOA4: apolipoprotein A-IV. Apoliprotein (apo) A-IV gene contains 3 exons separated by two introns. A sequence polymorphism has been identified in the 3'UTR of the third exon. The primary translation product is a 396-residue preprotein which after proteolytic processing is secreted its primary site of synthesis, the intestine, in association with chylomicron particles. Although its precise function is not known, apo A-IV is a potent activator of lecithin-cholesterol acyltransferase in vitro.
Aliases: apolipoprotein A-IV
- Molekulargewicht
- 45kDa
- Gen-ID
- 337
- HGNC
- 337
- UniProt
- P06727
- Pathways
- Lipid Metabolism
-
